WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003061718) MEDICAL ARTICLES HAVING ENZYMATIC SURFACES FOR LOCALIZED THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/061718    International Application No.:    PCT/US2003/002020
Publication Date: 31.07.2003 International Filing Date: 23.01.2003
IPC:
A61L 15/38 (2006.01), A61L 27/22 (2006.01), C12N 11/00 (2006.01)
Applicants: SCIMED LIFE SYSTEMS, INC. [US/US]; One Scimed Place, Maple Grove, MN 55311 (US)
Inventors: SHEPARD, Douglas, C.; (US)
Agent: BONHAM, David, B.; Mayer, Fortkort & Williams, PC, 251 North Avenue West, 2nd Floor, Westfield, NJ 07090 (US)
Priority Data:
10/057,596 24.01.2002 US
Title (EN) MEDICAL ARTICLES HAVING ENZYMATIC SURFACES FOR LOCALIZED THERAPY
(FR) ARTICLES MEDICAUX A SURFACES ENZYMATIQUES POUR TRAITEMENT LOCALISE
Abstract: front page image
(EN)An enzymatically active medical article is provided, which comprises a medical article and an enzyme disposed at or near a surface of the medical article such that the medical article is provided with an enzymatically active surface. The enzyme is selected, for example, from the group consisting of protease enzymes, glycosidase enzymes, enzymes that degrade cholesterol esters, enzymes that convert hydrocortisone to cortisone, enzymes that degrade oxalate, and enzymes that generate NO from arginine.
(FR)L'invention concerne un article médical enzymatiquement actif comprenant un article médical et une enzyme disposée au niveau ou au voisinage d'une surface de l'article médical de façon que cet article médical présente une surface enzymatiquement active. Par exemple, cette enzyme est choisie dans le groupe constitué par des enzymes protéases, des enzymes glycosidases, des enzymes dégradant les esters de cholestérol, des enzymes convertissant l'hydrocortisone en cortisone, des enzymes dégradant l'oxalate, ainsi que des enzymes produisant du NO à partir de l'arginine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)